Centurion Wealth Management LLC Purchases 62 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Centurion Wealth Management LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.8% during the 4th quarter, Holdings Channel reports. The firm owned 976 shares of the medical equipment provider’s stock after acquiring an additional 62 shares during the period. Centurion Wealth Management LLC’s holdings in Intuitive Surgical were worth $509,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. State Street Corp boosted its position in shares of Intuitive Surgical by 1.4% in the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after purchasing an additional 210,363 shares during the last quarter. FMR LLC boosted its position in shares of Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Intuitive Surgical by 1.9% in the 3rd quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after purchasing an additional 143,440 shares during the last quarter. Fisher Asset Management LLC boosted its position in shares of Intuitive Surgical by 1.8% in the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock worth $2,541,356,000 after purchasing an additional 86,488 shares during the last quarter. Finally, Wellington Management Group LLP boosted its position in shares of Intuitive Surgical by 1.7% in the 3rd quarter. Wellington Management Group LLP now owns 3,115,024 shares of the medical equipment provider’s stock worth $1,530,318,000 after purchasing an additional 53,383 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 408 shares of Intuitive Surgical stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the transaction, the executive vice president now owns 353 shares in the company, valued at approximately $208,181.75. This trade represents a 53.61 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares of the company’s stock, valued at $2,607,925.28. The trade was a 68.85 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.90% of the stock is owned by insiders.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $484.44 on Friday. The stock’s 50-day simple moving average is $567.46 and its 200 day simple moving average is $531.60. The company has a market cap of $172.55 billion, a P/E ratio of 75.58, a P/E/G ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on ISRG. Jefferies Financial Group raised their price target on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Raymond James lifted their target price on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. BTIG Research lifted their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Leerink Partners lifted their target price on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Finally, Evercore ISI lifted their target price on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.